Biomarkers of bone turnover in diagnosis and therapy of osteoporosis
- 14 August 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Wiener Medizinische Wochenschrift
- Vol. 162 (21-22), 464-477
- https://doi.org/10.1007/s10354-012-0133-9
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Secular trends in the incidence of hip and other osteoporotic fracturesOsteoporosis International, 2011
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to KnowJournal of Clinical Endocrinology & Metabolism, 2011
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisThe New England Journal of Medicine, 2009
- Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone ClubInternational Journal of Clinical Practice, 2008
- Use of proton pump inhibitors and risk of osteoporosis-related fracturesCMAJ : Canadian Medical Association Journal, 2008
- Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acidCancer, 2008
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007
- Psychotropic Medications and the Risk of FractureDrug Safety, 2007
- Hip fractures in the elderly: A world-wide projectionOsteoporosis International, 1992